Elastrin Therapeutics
South Carolina-based biotech developing novel therapies
Elastrin Therapeutics is a South-Carolina based biotechnology start-up with technology to restore hardened and damaged arteries by targeting the elastic fibers.
Visit website: https://www.elastrin.com/
Details last updated 06-Mar-2021
People at Elastrin Therapeutics
Naren Vyavahare
Co-founder at TGenTech, Elastrin Therapeutics and Professor of Bioengineering at Clemson University
Elastrin Therapeutics News
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022
Some really exciting developments with quite a few in clinical trials
Read more...Elastrin Therapeutics secures $10 million of funding for its calcification removal platform
Forever Healthy Foundation - 07-Apr-2022
Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications
Read more...AgomAb raises €62M in Series B round to advance regenerative medicine
Labiotech - 16-Mar-2021
Funds to bring the experimental drug to trials; symbolizes booming regenerative niche
Read more...Elastrin's novel therapies to reverse age-related vascular damage
Longevity Technology - 04-Mar-2021
Advancing technologies for tissue and organ rejuvenation with seed funding from Kizoo
Read more...
